JPS63196283A - Base for cell culture - Google Patents
Base for cell cultureInfo
- Publication number
- JPS63196283A JPS63196283A JP3048787A JP3048787A JPS63196283A JP S63196283 A JPS63196283 A JP S63196283A JP 3048787 A JP3048787 A JP 3048787A JP 3048787 A JP3048787 A JP 3048787A JP S63196283 A JPS63196283 A JP S63196283A
- Authority
- JP
- Japan
- Prior art keywords
- cell culture
- film
- cell
- proteins
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 40
- 239000000463 material Substances 0.000 claims abstract description 34
- 239000012510 hollow fiber Substances 0.000 claims abstract description 15
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- 235000000346 sugar Nutrition 0.000 claims abstract description 11
- 150000002632 lipids Chemical class 0.000 claims abstract description 10
- 150000008163 sugars Chemical class 0.000 claims abstract description 10
- 239000011148 porous material Substances 0.000 claims abstract description 7
- 239000000758 substrate Substances 0.000 claims description 42
- 230000001186 cumulative effect Effects 0.000 claims description 40
- 150000002500 ions Chemical class 0.000 claims description 10
- 238000010894 electron beam technology Methods 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 7
- 239000002861 polymer material Substances 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 2
- -1 tube Substances 0.000 abstract description 11
- 229920000642 polymer Polymers 0.000 abstract description 8
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 7
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 6
- 229920001184 polypeptide Polymers 0.000 abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000002131 composite material Substances 0.000 abstract description 4
- 229920001225 polyester resin Polymers 0.000 abstract description 2
- 239000004645 polyester resin Substances 0.000 abstract description 2
- 150000004671 saturated fatty acids Chemical class 0.000 abstract description 2
- 230000005855 radiation Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 44
- 108090000288 Glycoproteins Proteins 0.000 description 42
- 102000003886 Glycoproteins Human genes 0.000 description 42
- 239000000243 solution Substances 0.000 description 14
- 125000000524 functional group Chemical group 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000035755 proliferation Effects 0.000 description 8
- 238000009826 distribution Methods 0.000 description 7
- 210000004102 animal cell Anatomy 0.000 description 6
- 230000001678 irradiating effect Effects 0.000 description 6
- 230000021164 cell adhesion Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 4
- 229910052753 mercury Inorganic materials 0.000 description 4
- 230000007480 spreading Effects 0.000 description 4
- 238000003892 spreading Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229930186217 Glycolipid Natural products 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 125000001165 hydrophobic group Chemical group 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 108010039918 Polylysine Proteins 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-M hydroperoxide group Chemical group [O-]O MHAJPDPJQMAIIY-UHFFFAOYSA-M 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000010884 ion-beam technique Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- UTOPWMOLSKOLTQ-UHFFFAOYSA-N octacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O UTOPWMOLSKOLTQ-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- 208000030275 Chondronectin Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000012461 cellulose resin Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- TUTWLYPCGCUWQI-UHFFFAOYSA-N decanamide Chemical compound CCCCCCCCCC(N)=O TUTWLYPCGCUWQI-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 150000002298 globosides Chemical class 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- HSEMFIZWXHQJAE-UHFFFAOYSA-N hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(N)=O HSEMFIZWXHQJAE-UHFFFAOYSA-N 0.000 description 1
- 108700020610 human chondronectin Proteins 0.000 description 1
- 102000043667 human chondronectin Human genes 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- QEALYLRSRQDCRA-UHFFFAOYSA-N myristamide Chemical compound CCCCCCCCCCCCCC(N)=O QEALYLRSRQDCRA-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- LYRFLYHAGKPMFH-UHFFFAOYSA-N octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(N)=O LYRFLYHAGKPMFH-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- LTHCSWBWNVGEFE-UHFFFAOYSA-N octanamide Chemical compound CCCCCCCC(N)=O LTHCSWBWNVGEFE-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 150000004965 peroxy acids Chemical group 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002714 polyornithine Polymers 0.000 description 1
- 108010055896 polyornithine Proteins 0.000 description 1
- 229920006380 polyphenylene oxide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
この発明は、細胞培養用基材に関する。さらに詳細には
、動物細胞を培養するために使用される細胞培養用基材
に関するものである。DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a substrate for cell culture. More specifically, the present invention relates to a cell culture substrate used for culturing animal cells.
〈従来技術及び発明が解決しようとする問題点〉近年、
生物の細胞を培養し、その細胞の代謝活動により有用な
生理活性物質、例えば、ワクチン、ホルモン、インター
フェロン等を生産する研究が活発に行われている。<Prior art and problems to be solved by the invention> In recent years,
BACKGROUND OF THE INVENTION Research is actively being carried out to cultivate biological cells and produce useful physiologically active substances, such as vaccines, hormones, and interferons, through the metabolic activities of the cells.
このよ゛うな方法において、従来、接着性動物細胞の培
養は、ガラス、プラスチック製のシャーレ、試験管、培
養ビンなどを用いて行なわれてきた。In such methods, adherent animal cells have conventionally been cultured using glass or plastic petri dishes, test tubes, culture bottles, and the like.
また、最近、マイクロキャリアや中空糸を培養用基材と
して用い、より高密度の培養や、長期の培養を行なう試
みがなされつつある。接着性動物細胞を培養用基材上に
接着させ、増殖させるには、該基材表面と細胞の接着性
が良好であることと共に接着した細胞の形態、配列が、
細胞の伸展、増殖にを効な形態になっていることが必要
である。Recently, attempts have been made to use microcarriers and hollow fibers as culture substrates to achieve higher-density culture and longer-term culture. In order to allow adherent animal cells to adhere and proliferate on a culture substrate, it is necessary to have good adhesion between the cells and the surface of the substrate, as well as the morphology and arrangement of the adhered cells.
It is necessary to have a form that is effective for cell expansion and proliferation.
しかしながら、従来から細胞培養用基材として用いられ
ている高分子材料は賦形性、耐久性に優れるものの、上
記接着性等の点に関して不適当であり、高密度かつ長期
間の細胞培養を行なうことができず、いずれも十分な成
果を上げるに至っていない。However, although the polymer materials conventionally used as substrates for cell culture have excellent shapeability and durability, they are unsuitable in terms of adhesive properties, etc., and cannot be used for high-density and long-term cell culture. However, none of them have been able to achieve sufficient results.
この点を改善するため、生体高分子であるコラーゲンや
その変性物であるゼラチンを高分子材料上に塗布したも
の(特開昭58”−71884号公報参照)や、高分子
材料上に可溶性フィブロインの架橋体が積層された細胞
培養床(特開昭61−52280号公報参照)が提案さ
れている。In order to improve this point, we have developed methods that coat collagen, which is a biopolymer, and gelatin, which is a denatured product of collagen, on a polymer material (see Japanese Patent Application Laid-open No. 71884/1984), and coated soluble fibroin on a polymer material. A cell culture bed (see Japanese Patent Laid-Open No. 61-52280) has been proposed in which a crosslinked body of the following is laminated.
しかしながら、上記の従来技術は、高分子基材への糖や
蛋白質などの固定化が十分でなく容易に脱離してしまい
、細胞の接着性並びに接着した細胞の伸展性、増殖性お
よび活性維持が未だ十分でなく、高密度、長期間の細胞
培養ができないという問題点がある。However, in the above-mentioned conventional technology, sugars and proteins are not sufficiently immobilized on the polymeric substrate and easily detach, resulting in poor cell adhesion, as well as the spreadability, proliferation, and activity maintenance of adhered cells. There is still a problem that it is not sufficient and high-density, long-term cell culture is not possible.
く目 的〉
この発明は上記問題点に鑑みてなされたものであり、細
胞との接着性に優れ、細胞の増殖と機能維持を行うこと
のでき、高密度、長期間の細胞培養を可能ならしめる細
胞培養用基材を提供することを目的とする。Purpose This invention was made in view of the above-mentioned problems.It has excellent adhesion with cells, can proliferate cells and maintain their functions, and can be used for high-density, long-term cell culture. The purpose of the present invention is to provide a substrate for cell culture that retains moisture.
く問題点を解決するための手段および作用〉上記目的を
達成するため、この発明の細胞培養用基材としては、高
分子材料からなる基材が、単分子膜の累積膜で被覆され
ていると共に、上記累積膜に、糖、蛋白質、脂質および
これらの複合化合物(以下、糖蛋白質等と称する)の少
なくとも一種が担持されていることを特徴とするもので
ある。Means and Effects for Solving the Problems In order to achieve the above object, the cell culture substrate of the present invention comprises a substrate made of a polymeric material and covered with a cumulative monomolecular film. In addition, the cumulative membrane is characterized in that at least one of sugars, proteins, lipids, and complex compounds thereof (hereinafter referred to as glycoproteins, etc.) is supported.
なお、高分子材料は、多孔性材料であるのが好ましく、
基材は中空糸であるのが好ましい。また、累積膜は、紫
外線、電子線またはイオン照射により部分的に処理され
ているものが好ましい。Note that the polymer material is preferably a porous material,
Preferably, the substrate is a hollow fiber. Further, the cumulative film is preferably partially treated with ultraviolet rays, electron beams, or ion irradiation.
また、上記単分子膜の累積膜に、糖蛋白質等の少なくと
も1種類が部分的に、特に、格子模様、縞模様、水玉模
様等担持されているものが好ましい。Moreover, it is preferable that at least one type of glycoprotein or the like is partially supported on the cumulative monomolecular film, particularly in a lattice pattern, striped pattern, polka dot pattern, or the like.
上記の構成の細胞培養用基材によれば、高分子材料から
なる基材が、単分子膜の累積膜で被覆されているので、
基材表面には、上記累積膜を構成する材料および単分子
膜の累積状態に応じて、正または負の電荷を有する官能
基が存在し、この官能基は、糖蛋、白質等との接着に関
与し、糖蛋白質等を固定して担持する。より詳細には、
水に不溶性の有機化合物を水面上に展開することにより
、有機化合物の親水基、疎水基が所定方向に配向した単
分子膜を作製することができ、この単分子膜を適当な圧
力を加えて基材上に移し取ることにより、官能基が所定
方向に配向した状態の単分子膜で基材を被覆することが
できる。上記操作を繰返すことにより、官能基の配向が
制御された累積膜で前記基材を被覆することができ、官
能基の配向が制御された構造を有する累積膜により、前
記糖蛋白質等が担持される。そして、上記累積膜に担持
された糖蛋白質等は、細胞との接着に関与する。According to the cell culture substrate having the above structure, the substrate made of a polymeric material is coated with a cumulative monomolecular film.
On the surface of the base material, there are functional groups with positive or negative charges depending on the material constituting the cumulative film and the cumulative state of the monomolecular film. It immobilizes and supports glycoproteins, etc. More specifically,
By spreading a water-insoluble organic compound on the water surface, it is possible to create a monomolecular film in which the hydrophilic and hydrophobic groups of the organic compound are oriented in a predetermined direction. By transferring it onto a substrate, the substrate can be covered with a monomolecular film in which the functional groups are oriented in a predetermined direction. By repeating the above operation, the base material can be coated with a cumulative film in which the orientation of functional groups is controlled, and the glycoprotein, etc. is supported by the cumulative film having a structure in which the orientation of functional groups is controlled. Ru. Glycoproteins and the like supported on the cumulative membrane are involved in adhesion with cells.
また、細胞表面の細胞膜の構造は、脂質二重層の中に、
膜内粒子と呼ばれる各種の糖蛋白質、糖脂質が分布をも
って埋めこまれており、これらは自由に脂質二重層の中
を移動でき、上記糖蛋白質等の表面の官能基と接着する
。従って、前記単分子膜の累積膜は、前記高分子と糖蛋
白質等との接着を強固なものとし、糖蛋白質等を強固に
固定化し担持する。そして、糖蛋白質等の表面の官能基
を有する部位により細胞の接着性を高めることができ、
細胞の伸展、増殖が有効に行なわれる。In addition, the structure of the cell membrane on the cell surface consists of a lipid bilayer,
Various glycoproteins and glycolipids, called intramembrane particles, are embedded in a distributed manner, and these can freely move within the lipid bilayer and adhere to functional groups on the surface of the glycoproteins and the like. Therefore, the cumulative monomolecular film strengthens the adhesion between the polymer and glycoprotein, etc., and firmly immobilizes and supports the glycoprotein. Cell adhesion can be enhanced by sites with functional groups on the surface of glycoproteins, etc.
Cell expansion and proliferation are effectively carried out.
また、上記基材を被覆する累積膜が、紫外線等の照射に
より部分的に処理されて微細加工されると、親水性の程
度の異なる部分が微細模様状に配置された累積膜表面が
得られるので、糖蛋白質等の配向と分布を制御して糖蛋
白質等を固定化し担持できる。そして、上記のような構
造を有する細胞膜は、イオン結合、疎水結合等により細
胞が安定した形態、配列で基材の糖蛋白質等の上に接着
でき、ひいては細胞の伸展、増殖を促進することができ
る。特に、格子模様、縞模様、水玉模様等のように一定
のパターンをもって紫外線等で処理されているものは、
上記の効果を一層高めることができる。Furthermore, when the cumulative film covering the base material is partially treated and microfabricated by irradiation with ultraviolet rays, etc., a cumulative film surface in which portions with different degrees of hydrophilicity are arranged in a fine pattern can be obtained. Therefore, glycoproteins, etc. can be immobilized and supported by controlling the orientation and distribution of glycoproteins, etc. Cell membranes with the above-mentioned structure allow cells to adhere to glycoproteins, etc., as substrates in a stable form and arrangement due to ionic bonds, hydrophobic bonds, etc., and in turn promote cell expansion and proliferation. can. In particular, items that have been treated with ultraviolet light, etc. in a certain pattern such as a checkered pattern, striped pattern, polka dot pattern, etc.
The above effects can be further enhanced.
さらに、上記高分子材料が、多孔性材料であるときは、
多孔性材料の孔を通じて物質代謝が容易となり長期に亘
り細胞培養することができる。特に、前記高分子材料か
らなる基材が中空糸であるものは、中空部内や中空糸の
外側に培養液等を潅流することにより、中空糸上に細胞
を高密度に育成、増殖させることができる。Furthermore, when the polymer material is a porous material,
Metabolism becomes easy through the pores of the porous material, and cells can be cultured for a long period of time. In particular, when the base material made of the polymeric material is a hollow fiber, cells can be grown and multiplied at high density on the hollow fiber by perfusing a culture solution or the like into the hollow portion or outside of the hollow fiber. can.
以下、この発明の詳細な説明する。The present invention will be explained in detail below.
この発明の細胞培養用基材は、高分子材料からなる基材
と、この基材の表面を被覆する単分子膜の累積膜と、こ
の累積膜上に担持される糖蛋白質等とからなる。The cell culture substrate of the present invention comprises a substrate made of a polymeric material, a cumulative monomolecular film covering the surface of the substrate, and a glycoprotein etc. supported on the cumulative film.
上記高分子材料としては、賦形性、機械的強度を有する
ものであればいかなるものでも使用でき、例えば、ポリ
エチレン、ポリプロピレン、塩素化ポリエチレン、アイ
オノマー等のオレフィン系重合体、ポリテトラフルオロ
エチレン、ポリフッ化ビニリデン等のフッ素系樹脂、ポ
リスチレン等のスチレン系樹脂、ポリメチルメタクリレ
ート等のアクリル系樹脂、ポリビニルアルコール、ポリ
酢酸ビニル、ポリビニルアセタール、ポリアクリロニト
リル、ポリ塩化ビニル、ポリ塩化ビニリデン、ポリカー
ボネート、ボリアリレート2、ポリフェニレンオキサイ
ド、ポリエチレンテレフタレート、ポリブチレンテレフ
タレート等のポリエステル樹脂、エポキシ樹脂、ポリア
ミド、ポリイミド、ポリスルホン、セルロース系樹脂、
シリコーン樹脂、ポリウレタンなどの種々の重合体もし
くは共重合体またはそれらのブレンド物が例示できる。As the above-mentioned polymeric material, any material can be used as long as it has formability and mechanical strength. For example, olefinic polymers such as polyethylene, polypropylene, chlorinated polyethylene, and ionomers, polytetrafluoroethylene, and Fluorine resins such as vinylidene chloride, styrene resins such as polystyrene, acrylic resins such as polymethyl methacrylate, polyvinyl alcohol, polyvinyl acetate, polyvinyl acetal, polyacrylonitrile, polyvinyl chloride, polyvinylidene chloride, polycarbonate, polyarylate 2 , polyester resins such as polyphenylene oxide, polyethylene terephthalate, polybutylene terephthalate, epoxy resins, polyamides, polyimides, polysulfones, cellulose resins,
Examples include various polymers or copolymers such as silicone resins and polyurethanes, or blends thereof.
上記高分子材料からなる基材は、種々の形態に形成でき
、例えば、シャーレ、フラスコ等の成形品の他、フィル
ム、チューブ、中空糸、繊維、粒子等の形態が例示でき
る。これらの形態のうち、長期に亘り細胞培養を行なう
には、物質代謝を容易にする孔を有する多孔性高分子材
料が好ましく、また、高密度培養を行なうには、チュー
ブ、中空糸の形状が好適である。特に、物質代謝が容易
で、高密度培養を長期に亘り行なえる多孔性高分子材料
からなる中空糸が好ましい。この中空糸を用いるとき、
培養液を、中空糸の中空部または外側に潅流させ、必要
に応じて炭酸ガスや空気等を上記中空糸の中空部等に送
ることにより、細胞を中空糸上で育成し、増殖すること
ができる。なお、前記中空糸としては、種々の大きさの
ものが使用でき、例えば、内径50〜1000μm程度
のものが用いられる。The base material made of the above-mentioned polymeric material can be formed into various shapes, including molded products such as petri dishes and flasks, as well as films, tubes, hollow fibers, fibers, particles, and the like. Among these forms, for long-term cell culture, porous polymeric materials with pores that facilitate material metabolism are preferable, and for high-density culture, tubes and hollow fibers are preferable. suitable. Particularly preferred are hollow fibers made of porous polymeric materials that are easy to metabolize and can be cultured at high density for a long period of time. When using this hollow fiber,
Cells can be grown and proliferated on the hollow fiber by perfusing the culture solution into the hollow part or the outside of the hollow fiber, and sending carbon dioxide gas, air, etc. into the hollow part of the hollow fiber as necessary. can. Note that the hollow fibers can be of various sizes, and for example, those having an inner diameter of about 50 to 1000 μm are used.
また、この発明にかかる細胞培養用基材をマイクロキャ
リアー法のビーズ担体として使用する場合には、前記高
分子材料は100〜300μ畠程度の粒径のものが用い
られる。Further, when the cell culture substrate according to the present invention is used as a bead carrier in a microcarrier method, the polymer material used has a particle size of about 100 to 300 μm.
この発明の細胞培養用基材は、上記高分子基材と糖蛋白
質等との接着を強固なものにするため、上記高分子材料
からなる基材の表面が単分子膜の累積膜で被覆されてい
る。In the cell culture substrate of the present invention, the surface of the substrate made of the polymeric material is coated with a cumulative monomolecular film in order to strengthen the adhesion between the polymeric substrate and glycoprotein, etc. ing.
上記単分子膜は、水に不溶性の有機化合物を水面上に展
開することにより作製することができ、展開状態では親
水基が水相側に、疎水基が気相側に配向する。また、上
記単分子膜は、適当な圧力を加えて前記基材上に移し取
ることにより、単分子膜の官能基が所定方向に配向した
状態で前記基材を被覆することができる。従って、上記
操作を繰返すことにより、親水基、疎水基の配向および
構造が制御された累積膜を作製することができる。The above-mentioned monomolecular film can be produced by spreading a water-insoluble organic compound on a water surface, and in the developed state, hydrophilic groups are oriented toward the water phase side and hydrophobic groups are oriented toward the gas phase side. Furthermore, by transferring the monomolecular film onto the base material by applying an appropriate pressure, the base material can be coated with the functional groups of the monomolecular film oriented in a predetermined direction. Therefore, by repeating the above operations, it is possible to produce a cumulative film in which the orientation and structure of the hydrophilic and hydrophobic groups are controlled.
特に、上記累積膜は表面圧を調整することにより前記官
能基の配向状態を制御できるので、このようにして作製
された累積膜は、糖蛋白質等との接着を強固なものとし
、ひいては細胞との接着性、細胞の伸展、増殖に有用で
ある。In particular, since the orientation of the functional groups in the cumulative film can be controlled by adjusting the surface pressure, the cumulative film produced in this way has strong adhesion with glycoproteins, etc., and can even be used to bond with cells. useful for cell adhesion, cell spreading, and proliferation.
上記単分子□膜を形成する有機化合物としては、低分子
化合物、高分子化合物等の多くの有機化合物が使用でき
る。低分子化合物としては、例えば、カプリル酸、カプ
リン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ス
テアリン酸、ジオキシステアリン酸、ベヘン酸、リグノ
セリン酸、モンタン酸等の飽和脂肪酸、オレイン酸、エ
ライジン酸、エルカ酸、リノール酸、リルン酸、エレオ
ステアリン酸、アラキドン酸、リシルイン酸等の不飽和
脂肪酸等の脂肪酸;上記脂肪酸からの誘導体、例えば、
メタノール、エタノール、プロピルアルコール、イソプ
ロピルアルコール、エチレングリコール、ジエチレング
リコール、ポリエチレングリコール、プロピレングリコ
ール、ポリプロピレングリコール、グリセリン、トリメ
チロールプロパン、ペンタエリトリトール、ソルビタン
等の一価または多価アルコールとのエステル;カプリル
酸アミド、カプリン酸アミド、ラウリン酸アミド、ミリ
スチン酸アミド、パルミチン酸アミド、オレイン酸アミ
ド、ステアリン酸アミド等の前記脂肪酸のアミド;ラウ
リルアルコール、セチルアルコール、オレイルアルコー
ル、ステアリルアルコール等の高級アルコール;あるい
は上記脂肪酸のビニル化合物等が例示できる。また、上
記高分子化合物としては、種々の高分子が使用できるが
、天然ペプチド、合成ポリペプチド等が好ましく、所望
する官能基に応じて適宜選択することができる。As the organic compound forming the monomolecular □ film, many organic compounds such as low-molecular compounds and high-molecular compounds can be used. Examples of low-molecular compounds include saturated fatty acids such as caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, dioxystearic acid, behenic acid, lignoceric acid, and montanic acid, oleic acid, elaidic acid, Fatty acids such as unsaturated fatty acids such as erucic acid, linoleic acid, lylunic acid, eleostearic acid, arachidonic acid, lysyllic acid; derivatives from the above fatty acids, e.g.
Esters with monohydric or polyhydric alcohols such as methanol, ethanol, propyl alcohol, isopropyl alcohol, ethylene glycol, diethylene glycol, polyethylene glycol, propylene glycol, polypropylene glycol, glycerin, trimethylolpropane, pentaerythritol, sorbitan; caprylic acid amide, Amides of the above fatty acids such as capric acid amide, lauric acid amide, myristic acid amide, palmitic acid amide, oleic acid amide, and stearic acid amide; higher alcohols such as lauryl alcohol, cetyl alcohol, oleyl alcohol, and stearyl alcohol; or Examples include vinyl compounds. Moreover, various polymers can be used as the above-mentioned polymer compound, but natural peptides, synthetic polypeptides, etc. are preferable, and can be appropriately selected depending on the desired functional group.
なお、上記ポリペプチドは、直鎖状、環状ポリペプチド
であってもよい。上記ポリペプチドのうち、特に、正電
荷を有するポリリジンやポリオルニチンのポリアミノ酸
が好ましい。これらは、表面に負の電荷を有する前記糖
蛋白質等の接着を促進する。Note that the above polypeptide may be a linear or cyclic polypeptide. Among the above polypeptides, positively charged polyamino acids such as polylysine and polyornithine are particularly preferred. These promote adhesion of the above-mentioned glycoproteins etc. that have a negative charge on the surface.
また、上記基材を被覆する累積膜は、糖蛋白質等の配向
と分布を制御して前記糖蛋白質等を担持するため、紫外
線、電子線またはイオン照射処理、特に、部分的に照射
処理されているのが好ましい。In addition, the cumulative film covering the base material may be subjected to ultraviolet ray, electron beam or ion irradiation treatment, particularly partial irradiation treatment, in order to control the orientation and distribution of the glycoprotein, etc. and support the glycoprotein, etc. It is preferable to be there.
前記累積膜を上記紫外線、電子線またはイオン照射処理
する方法は、いずれも慣用の手段が用いられる。これら
の表面処理により、前記累積膜の官能基の分布を制御す
ることができ、前記累積膜の表面に、カルボキシ基、カ
ルボニル基、ヒドロパーオキシド基等の官能基が導入さ
れ、親水性の程度の異なる部分を微細模様状に形成でき
るので、糖蛋白質等を官能基の配向、分布状態が制御さ
れた状態で累積膜上に強固に接着させ、ひいては上記糖
蛋白質等の表面での細胞の伸展、増殖を促進することが
できる。Any conventional means may be used to treat the cumulative film with ultraviolet rays, electron beams, or ion irradiation. These surface treatments can control the distribution of functional groups in the cumulative film, and introduce functional groups such as carboxyl groups, carbonyl groups, and hydroperoxide groups onto the surface of the cumulative film, thereby changing the degree of hydrophilicity. Since different parts of the glycoprotein can be formed into a fine pattern, glycoproteins, etc. can be firmly adhered to the cumulative membrane with the orientation and distribution of functional groups controlled, which in turn allows cells to spread on the surface of the glycoproteins, etc. , can promote proliferation.
上記紫外線としては、前記基材を被覆する累積膜表面で
化学反応を生じさせる波長のものが使用され、紫外線の
うち、200ni未満の遠紫外線は、光エネルギーが大
きいため、より効率的に処理することができる。The above-mentioned ultraviolet rays are those with a wavelength that causes a chemical reaction on the surface of the cumulative film that coats the base material. Among the ultraviolet rays, far ultraviolet rays of less than 200 ni have large optical energy, so they can be processed more efficiently. be able to.
なお、上記紫外線を放射する光源としては、クセノンア
ーク、メタルハライドランプなども使用できるが、大面
積の処理が可能な水銀灯やコヒーレントで微細加工が可
能なレーザが好適に用いられる。上記水銀灯としては、
388nmの波長が主である高圧水銀灯、25B、7n
a+および184.9no+の波長の光を同時に放射す
る低圧水銀灯が例示できる。Although a xenon arc, a metal halide lamp, or the like can be used as the light source for emitting the ultraviolet rays, a mercury lamp that can process a large area or a laser that can perform coherent and fine processing is preferably used. As for the above mercury lamp,
High-pressure mercury lamp, whose main wavelength is 388 nm, 25B, 7n
An example is a low-pressure mercury lamp that simultaneously emits light of wavelengths a+ and 184.9no+.
また、レーザとしては、Ar、He−Cd、N2等のレ
ーザの他に、短波長と高出力の光を放射するエキシマレ
ーザが利用できる。エキシマレーザは、短時間に高いエ
ネルギーを累積膜に与え、前記累積膜を化学的および物
理的に大きく改質できるため、好適に用いられる。In addition to lasers such as Ar, He-Cd, and N2, excimer lasers that emit short-wavelength and high-output light can be used as lasers. An excimer laser is preferably used because it applies high energy to the accumulated film in a short time and can significantly modify the accumulated film chemically and physically.
上記紫外線による処理は、紫外線を種々の雰囲気中で累
積膜の表面に照射することにより行なわれる。例えば、
空気中で紫外線を照射すると、前記累積膜の表面にカル
ボニル基が生成する他、ヒドロペルオキシド基や過酸基
も生じる。The treatment with ultraviolet rays is carried out by irradiating the surface of the cumulative film with ultraviolet rays in various atmospheres. for example,
When ultraviolet rays are irradiated in the air, not only carbonyl groups are generated on the surface of the cumulative film, but also hydroperoxide groups and peracid groups are generated.
また、前記電子線処理における電子線源としては、各種
の電子線加速器、コックロフトワルトン型、バンプグラ
フ型、共振変圧型等が使用でき、また、電子線としては
、累積膜の種類および所望する処理の程度に応じて種々
の照射線量、例えば、1〜50M radのものが使用
できる。Further, as the electron beam source in the electron beam processing, various electron beam accelerators, Cockroft-Walton type, bump graph type, resonant transformation type, etc. can be used. Depending on the extent of treatment, various irradiation doses can be used, for example from 1 to 50 M rad.
イオン処理としては、慣用のイオンビーム照射′装置が
用いられ、イオンシャワーにより試料全体に照射される
他、マスクや集束イオンビームの採用により、部分的、
微細模様に照射される。イオンとしては、各種のイオン
を用いることができ、特に限定されないが、He +、
A r 十、C+、N+等のイオンを例示することがで
きる。また、好適なイオンエネルギーの値としては0.
05kev〜500Kevが挙げられ、この値未満では
効果が小さく、またこの値を越えると基材の炭化が顕著
に進み好ましくない。For ion processing, a conventional ion beam irradiation device is used, and in addition to irradiating the entire sample with an ion shower, partial irradiation is performed using a mask and a focused ion beam.
It is irradiated in a fine pattern. Various ions can be used as the ions, including but not limited to He +,
Examples include ions such as A r +, C+, and N+. Further, a suitable value of ion energy is 0.
If the value is less than this value, the effect will be small, and if it exceeds this value, the carbonization of the base material will proceed significantly, which is not preferable.
上記紫外線等の照射は、前記累積膜表面の全面に行なっ
てもよいが、紫外線等の照射を部分的に行ない、微細加
工することにより、糖蛋白質等の配向と分布を制御して
糖蛋白質等を固定、担持させ、糖蛋白質等の表面での細
胞の伸展と増殖を増大させることができる。紫外線等を
部分的に照射する場合、格子状、縞模様、水玉模様等の
微細模様に照射することにより、糖蛋白質等の配向、分
布を精度よく制御できるので、上記効果をさらに増進で
きる有用な表面を形成することができる。The above-mentioned irradiation with ultraviolet rays, etc. may be performed on the entire surface of the cumulative film surface, but by irradiating with ultraviolet rays, etc. partially and performing microfabrication, the orientation and distribution of glycoproteins, etc. can be controlled, and glycoproteins, etc. can be immobilized and supported to increase cell spread and proliferation on surfaces such as glycoproteins. When partially irradiating ultraviolet rays, etc., the orientation and distribution of glycoproteins, etc. can be precisely controlled by irradiating fine patterns such as lattice, striped, and polka dot patterns, which is a useful method that can further enhance the above effects. surface can be formed.
また、エキシマレーザおよび電子線は、短時間に高いエ
ネルギーを前記累積膜に与え、累積膜を化学的に大きく
改質できる他、累積膜表面を微細な凹凸状に微細加工す
る物理的改質もできるので、糖蛋白質等の固定、担持だ
けでなく、配向および分布もより一層制御することがで
き、細胞の物質代謝をも促進できるという利点がある。In addition, excimer lasers and electron beams apply high energy to the accumulated film in a short period of time, making it possible to significantly modify the accumulated film chemically, as well as physically modifying the surface of the accumulated film into minute irregularities. This has the advantage that not only the immobilization and support of glycoproteins, etc., but also the orientation and distribution can be further controlled, and that it is also possible to promote cellular metabolism.
なお、上記微細模様は、適宜の手段により形成すること
ができ、例えば、フォトマスクを使用して前記紫外線等
を照射したり、レーザ、電子線を操作することにより、
上記微細模様状にミクロンオーダーの精度で所望の間隔
を有する模様状に描くことができる。Note that the above-mentioned fine pattern can be formed by appropriate means, for example, by irradiating the ultraviolet rays etc. using a photomask, or by operating a laser or an electron beam.
The above-mentioned fine pattern can be drawn with desired spacing with micron-order accuracy.
上記のような累積膜上には、糖蛋白質等が担持されてい
る。ここで用いる糖蛋白質等は、細胞と親和性があり、
細胞の接着を促進するものであればいずれも用いること
ができ、例えば、ラクトース、ガラクトース等のオリゴ
糖、アルブミン等の蛋白質、リン脂質等の脂質、グロボ
シド、ガングリオシド等の糖と脂質との複合体である糖
脂質、細胞質や血清中に含まれる脂質と蛋白質との複合
体であるリボ蛋白質、糖と蛋白質との複合体である糖蛋
白質等が挙げられ、特にオリゴ糖、コラーゲン、ゼラチ
ン、フィブロネクチン、ラミニン、コンドロネクチン、
ビトロネクチン、フィブリン等の糖蛋白質が好適に用い
られ、これらは2種またはそれ以上組み合せて使用する
ことも有用である。基材上に糖蛋白質等を担持する方法
は、従来の技術がいずれも応用できる。一般には、上記
高分子基材を累積膜で被覆した後、上記の糖蛋白質等の
1種類または2種類以上を含有する溶液に浸漬したり、
上記単分子膜で基材を被覆するのと同様な方法で被覆し
たり、または該溶液を累積膜表面に塗布した後、乾燥す
ることにより行われる。Glycoproteins and the like are supported on the above-mentioned cumulative membrane. The glycoproteins used here have an affinity for cells,
Any substance that promotes cell adhesion can be used, such as oligosaccharides such as lactose and galactose, proteins such as albumin, lipids such as phospholipids, and complexes of sugars and lipids such as globosides and gangliosides. Examples include glycolipids, which are glycolipids, riboproteins, which are complexes of lipids and proteins contained in the cytoplasm and serum, and glycoproteins, which are complexes of sugars and proteins.In particular, oligosaccharides, collagen, gelatin, fibronectin, laminin, chondronectin,
Glycoproteins such as vitronectin and fibrin are preferably used, and it is also useful to use two or more of these in combination. Any conventional technique can be applied to the method of supporting glycoprotein etc. on the substrate. In general, after the polymer base material is coated with a cumulative film, it is immersed in a solution containing one or more of the above glycoproteins, etc.
This can be carried out by coating the base material with the monomolecular film in the same manner as described above, or by applying the solution to the surface of the accumulated film and then drying it.
この際、糖蛋白質等が変性しにくい条件で乾燥するのが
好ましい。At this time, it is preferable to dry under conditions that do not easily denature glycoproteins and the like.
上記糖蛋白質等の担持は、累積膜表面の全面に積層して
もよいが、累積膜表面に部分的に、特にパターン化して
担持したものが好ましく、このようにパターン化して担
持することにより、糖蛋白質等の上に接着する細胞の配
置を制御でき、ひいては細胞の接着性が安定化し、細胞
の伸展、増殖および機能発現を有利にすることができる
。さらに、糖蛋白質等を上記のように部分的に担持する
場合、特に、格子状、縞模様、水玉模様等の微細模様に
担持することにより、上記効果をさらに増進できる有用
な表面を形成することができる。累積膜上に糖蛋白質等
をパターン化して担持するには、例えば、スクリーン印
刷等の技術を応用して行なうことができる。The above-mentioned glycoproteins, etc. may be supported on the entire surface of the cumulative film, but it is preferable to support them partially on the surface of the cumulative film, particularly in a patterned manner. It is possible to control the arrangement of cells adhering to glycoproteins, etc., which in turn stabilizes cell adhesion, making cell spreading, proliferation, and functional expression advantageous. Furthermore, when glycoproteins and the like are partially supported as described above, a useful surface that can further enhance the above effects can be formed by supporting them in a fine pattern such as a lattice pattern, a striped pattern, a polka dot pattern, etc. Can be done. Glycoproteins and the like can be patterned and supported on the cumulative film by applying techniques such as screen printing, for example.
この発明の細胞培養用基材は、種々の細胞の培養に使用
することができ、細胞の種類は特に限定されず生体由来
細胞、ハイブリドーマ−等が挙げられ、例えば、チャイ
ニーズハムスター肺由来細胞v−79、ヒト子宮癌由来
細胞He L a s ヒト胎児肺由来細胞MRC−5
、ヒト肝由来細胞Chang Llver 、ヒト肺由
来正二倍体線維芽細胞工RC−90、ヒトリンパ腫由来
ナマルバ細胞等が例示される。The cell culture substrate of the present invention can be used to culture various cells, and the type of cells is not particularly limited, and examples include living body-derived cells, hybridomas, etc. For example, Chinese hamster lung-derived cells v- 79, human uterine cancer-derived cells HeLas human fetal lung-derived cells MRC-5
, human liver-derived cells Chang Llver, human lung-derived eudiploid fibroblast cells RC-90, human lymphoma-derived Namalva cells, and the like.
また、この発明の細胞培養用基材を用いて動物細胞を培
養する場合、培養する細胞の種類に応じて種々の培養液
が用いられ、細胞の増殖に適した至適温度、pH等の条
件で培養が行なわれる。Furthermore, when culturing animal cells using the cell culture substrate of the present invention, various culture solutions are used depending on the type of cells to be cultured, and conditions such as optimal temperature and pH suitable for cell proliferation are used. Culture is carried out in
本発明の細胞培養用基材は、従来公知の種々のモジュー
ルにて、動物細胞の増殖に適用できる。The cell culture substrate of the present invention can be applied to the proliferation of animal cells in various conventionally known modules.
本発明の細胞培養基材としてフィルム状基材を用いたモ
ジュールの一例を、添付図面に基づいて説明すると以下
の通りである。An example of a module using a film-like substrate as a cell culture substrate of the present invention will be described below based on the accompanying drawings.
温情図面に示す細胞培養器は、サポートスクリーン(2
)上に載置されたフィルム状細胞培養用基材(1)の両
端が、ポリカーボネート等からなるハウジング(3)内
の両側に設けられたスペーサ(6)により保持されてい
る。また、上記ハウジングG)には、増殖させる細胞懸
濁液をハウジング(3)内に満すための孔(4)が設け
られていると共に、培養液を潅流させるための管(5)
が取付られている。なお、上記孔(4)は、細菌等が侵
入するのを防止するため、フィルター付きのM(ア)で
被冠されている。The cell culture vessel shown in the diagram is equipped with a support screen (2
) Both ends of the film-like cell culture substrate (1) placed on the top are held by spacers (6) provided on both sides in a housing (3) made of polycarbonate or the like. Further, the housing G) is provided with a hole (4) for filling the housing (3) with a cell suspension to be proliferated, and a tube (5) for perfusing the culture solution.
is installed. The hole (4) is covered with a filter (M) to prevent bacteria from entering.
上記の細胞培養器を用いて細胞を増殖させるには、上記
孔(4)から細胞懸濁液を注入して細胞を前記基材(1
)上に接着させると共に、前記孔(4)をフィルタ付き
の上記蓋(7)で被冠し、所定の培養条件の下、上記培
養液を前記管(5)を通じて所定時間潅流させることに
より行なわれる。In order to proliferate cells using the cell culture device described above, a cell suspension is injected through the hole (4) and the cells are grown in the substrate (1).
), the hole (4) is covered with the lid (7) with a filter, and the culture solution is perfused through the tube (5) for a predetermined time under predetermined culture conditions. It will be done.
〈実施例〉
以下、実施例に基づいてこの発明をより詳細に説明する
。<Examples> Hereinafter, the present invention will be described in more detail based on examples.
実施例1および比較例
清浄な水面にポリリジン(分子量4.000−15.0
00)の酢酸アンモニウム溶液(濃度0 、 OLvt
%)を滴下し、表面圧を0.2dync/cmに保って
単分子膜を展開した。この単分子膜をポリエチレンテレ
フタレート(膜厚100μm、径45關φの円形フィル
ム)上に水平付着法によって移し取る操作を20回繰り
返すことで、その累積膜を積層した複合膜を得た。この
複合膜を、石英板上に描かれたクロムマスクの画像を通
して250〜300 nm波長の紫外線をDeepUV
露光装置により30分間照射し、1μmの格子状模様(
処理部幅1μM)に処理されたフィルムを得た。この処
理フィルムを径45m+sφのガラスシャーシにセット
し、高圧蒸気滅菌後、無菌のフィブロネクチン(シグマ
社製、牛血清より採取)のトリス緩衝溶液(濃度0.1
a+g/ ml )を塗布し、室温で乾燥させた。こ
れらの操作は全て無菌的に行なった。このシャーレでチ
ャイニーズハムスター肺由来細胞(V−79)を培養し
た。培養液として10重量%牛脂児血清を含むイーグル
MEM培地を用いた。Example 1 and Comparative Examples Polylysine (molecular weight 4.000-15.0
00) ammonium acetate solution (concentration 0, OLvt
%) was added dropwise, and a monomolecular film was developed while keeping the surface pressure at 0.2 dync/cm. By repeating the operation of transferring this monomolecular film onto polyethylene terephthalate (a circular film with a thickness of 100 μm and a diameter of 45 mm) by a horizontal adhesion method 20 times, a composite film in which the cumulative films were laminated was obtained. This composite film was exposed to deep UV light with a wavelength of 250 to 300 nm through a chrome mask image drawn on a quartz plate.
It was irradiated for 30 minutes using an exposure device, and a 1 μm grid pattern (
A film treated with a treated area width of 1 μM) was obtained. This treated film was set in a glass chassis with a diameter of 45 m + sφ, and after high-pressure steam sterilization, a Tris buffer solution (concentration 0.1
a+g/ml) and dried at room temperature. All these operations were performed aseptically. Chinese hamster lung-derived cells (V-79) were cultured in this petri dish. Eagle's MEM medium containing 10% by weight tallow serum was used as the culture medium.
培養液1ml当たりI X 104個の培養細胞を播種
し、5%炭酸ガス、95%空気雰囲気の温度37℃の環
境下、7日間の培養を行なったところ、培養液1 xI
当り平均6.4×106個の細胞数となり、良好な増殖
が観察された。When cultured cells were seeded at I x 104 cells per ml of culture solution and cultured for 7 days in an environment of 5% carbon dioxide and 95% air at a temperature of 37°C, 1 x I of culture solution was grown.
The average number of cells per cell was 6.4 x 106, and good proliferation was observed.
一方、ポリエチレンテレフタレートフィルムをそのまま
用いたほかは、実施例1谷同様に試験を行なった比較例
では、培養液1 xI当り平均9.0×105の細胞数
となった。On the other hand, in a comparative example in which the test was conducted in the same manner as in Example 1 except that the polyethylene terephthalate film was used as it was, the average number of cells was 9.0 x 105 per 1 x I of culture solution.
実施例2
実施例1と同じ手順に従ってポリ(γ−ベンジンーL−
グルタメート)(分子量15,000−30.000)
の累積膜(20回繰作)を四弗化エチレン樹脂多孔質フ
ィルム(住人電気工業■製、フロロポアFP−010)
に積層して、その複合膜を得た。このフィルムを添付図
面に示す細胞培養器(内径47■φ)に装着し、全体を
高圧蒸気滅菌後、無菌のコラーゲン溶液(タイプl、濃
度0.3%)を孔(4)から注入し、1分間静置後、溶
液を排出して、室温で乾燥させた。ついで孔(4)から
ヒト胎児包皮由来細胞(Plov 7000)のイーグ
ルMEM(to%牛脂児血清添加)懸濁液(細胞数2X
104個/ xI )を満した。孔(4)には、細菌を
カットするフィルターの蓋(7)をし、管(5)を通し
て、新鮮なイーグルMEM培地を潅流し、37℃で1週
間培養を行なった。Example 2 Poly(γ-benzine-L-
glutamate) (molecular weight 15,000-30,000)
The cumulative film (repeated 20 times) was made into a polytetrafluoroethylene resin porous film (Fluoropore FP-010, manufactured by Judenki Kogyo ■).
was laminated to obtain a composite membrane. This film was attached to the cell culture vessel (inner diameter 47 φ) shown in the attached drawing, and after sterilizing the whole thing with high-pressure steam, a sterile collagen solution (type I, concentration 0.3%) was injected through the hole (4). After standing for 1 minute, the solution was drained and dried at room temperature. Then, from the hole (4), a suspension of human fetal foreskin-derived cells (Plov 7000) in Eagle MEM (to% tallow serum added) (cell number 2X) was added.
104 pieces/xI). The hole (4) was covered with a filter lid (7) for cutting bacteria, and fresh Eagle's MEM medium was perfused through the tube (5) and cultured at 37° C. for one week.
培養終了後、フィルムに付着している細胞数を測定した
ところ、5.5×104個/′11に繁殖していること
がわかった。After the culture was completed, the number of cells attached to the film was measured, and it was found that the number of cells had grown to 5.5 x 104 cells/'11.
〈発明の効果〉
以上のように、この発明の細胞培養用基材によれば、高
分子材料からなる基材が、単分子膜の累積膜で被覆され
ていると共に、累積膜上に糖蛋白質等が担持されている
ので、前記基材から糖蛋白質等が脱落することなく、前
記基材へ糖蛋白質等を強固に固定化し担持することがで
きる。また、上記糖蛋白質等は、細胞との接着性並びに
細胞の伸展性および増殖性に優れるので、高密度かつ長
期間の細胞培養が可能となるという特有の効果を奏する
。従って、この発明の細胞培養用基材は、動物細胞の培
養によるホルモン等の有用物の生産システムに利用でき
る他、例えばインスリン産生細胞を基材表面に接着、培
養することにより人工膵臓が形成できるように人工臓器
の構築に利用できる。<Effects of the Invention> As described above, according to the cell culture substrate of the present invention, the substrate made of a polymeric material is coated with a cumulative monomolecular film, and a glycoprotein is coated on the cumulative film. Since the glycoproteins and the like are supported, the glycoproteins and the like can be firmly immobilized and supported on the base material without falling off from the base material. In addition, the above-mentioned glycoproteins and the like have excellent adhesion to cells, as well as cell spreadability and proliferation, and therefore have the unique effect of enabling high-density and long-term cell culture. Therefore, the cell culture substrate of the present invention can be used in a system for producing useful products such as hormones by culturing animal cells, and can also form an artificial pancreas by, for example, attaching and culturing insulin-producing cells to the surface of the substrate. It can be used to construct artificial organs.
添付図面は本発明の細胞培養用基材を用いた細胞培養器
の一例を示す断面図である。
(1)・・・細胞培養用基材、(2)・・・サポートス
クリーン、(3)・・・ハウジング、(4)・・・孔、
(5)・・・管。The accompanying drawing is a sectional view showing an example of a cell culture vessel using the cell culture substrate of the present invention. (1)... Substrate for cell culture, (2)... Support screen, (3)... Housing, (4)... Hole,
(5)...Tube.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3048787A JPS63196283A (en) | 1987-02-12 | 1987-02-12 | Base for cell culture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3048787A JPS63196283A (en) | 1987-02-12 | 1987-02-12 | Base for cell culture |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63196283A true JPS63196283A (en) | 1988-08-15 |
Family
ID=12305191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3048787A Pending JPS63196283A (en) | 1987-02-12 | 1987-02-12 | Base for cell culture |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63196283A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162225A (en) * | 1989-03-17 | 1992-11-10 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
JPH07308186A (en) * | 1994-10-26 | 1995-11-28 | Kanegafuchi Chem Ind Co Ltd | Tool for controlling cell sequence and method for controlling cell sequence |
WO1996015223A1 (en) * | 1994-11-14 | 1996-05-23 | Universite Catholique De Louvain | Biomaterial and method for obtaining it |
US6605638B1 (en) * | 2000-12-20 | 2003-08-12 | D-Pharm Limited | Use of branched chain fatty acids and derivatives thereof for inhibition of P-glycoprotein |
-
1987
- 1987-02-12 JP JP3048787A patent/JPS63196283A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162225A (en) * | 1989-03-17 | 1992-11-10 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
JPH07308186A (en) * | 1994-10-26 | 1995-11-28 | Kanegafuchi Chem Ind Co Ltd | Tool for controlling cell sequence and method for controlling cell sequence |
WO1996015223A1 (en) * | 1994-11-14 | 1996-05-23 | Universite Catholique De Louvain | Biomaterial and method for obtaining it |
BE1008955A3 (en) * | 1994-11-14 | 1996-10-01 | Univ Catholique Louvain | Process for obtaining and products obtained biomaterials. |
US6605638B1 (en) * | 2000-12-20 | 2003-08-12 | D-Pharm Limited | Use of branched chain fatty acids and derivatives thereof for inhibition of P-glycoprotein |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Catros et al. | Layer-by-layer tissue microfabrication supports cell proliferation in vitro and in vivo | |
US5900361A (en) | System and method for rapid positioning of cells on a substratum | |
Gümüşderelioğlu et al. | Biomodification of non-woven polyester fabrics by insulin and RGD for use in serum-free cultivation of tissue cells | |
JPS63196286A (en) | Base for cell culture | |
JPS63198978A (en) | Base material for cultivating cell | |
Turunen et al. | Chemical and topographical patterning of hydrogels for neural cell guidance in vitro | |
JP2010516273A (en) | Method for treating cultured cells | |
US5010009A (en) | Material for cell attachment and growth | |
JPS63198975A (en) | Base material for cultivating cell | |
JPS63196281A (en) | Substrate for cell culture | |
Gelli et al. | Cross-linked porous gelatin microparticles with tunable shape, size, and porosity | |
JPS63196283A (en) | Base for cell culture | |
JPS63196273A (en) | Substrate for cell culture | |
Taguchi et al. | Immobilization of human vascular endothelial growth factor (VEGF165) onto biomaterials: an evaluation of the biological activity of immobilized VEGF165 | |
JPS63198980A (en) | Base material for cultivating cell | |
JPS63196272A (en) | Substrate material for cell culture | |
JPS63198981A (en) | Base material for cultivating cell | |
JPS63196282A (en) | Base for cell culture | |
JPS63196271A (en) | Substrate for cell culture | |
JP2777392B2 (en) | Cell culture substrate and method for producing the same | |
JPS63198976A (en) | Base material for cultivating cell | |
JPH03266980A (en) | Base material for cell culture and production of cell aggregate using same | |
JPS63198977A (en) | Base material for cultivating cell | |
JPS63198979A (en) | Base material for cultivating cell | |
JPS63196278A (en) | Substrate for cell culture |